Skip to main content

Berberian Lance's Form 4 filing

Labcorp Holdings Inc. (LH) · filed Aug 7, 2024

Accession no.
0001127602-24-021768
Filed
Aug 7, 2024
Trade date
Aug 5, 2024
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions. Open-market sales total $2.77M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Berberian LanceCIK 0001102900Officer (EVP, CIO & CTO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 5, 2024Common StockSSaleDisposed−2,245$229.79F1−$515,878.5525,769Direct
Aug 5, 2024Common StockSSaleDisposed−9,848$228.95F2−$2,254,699.615,921Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price of $229.785 per share represents a weighted average of sales prices ranging from $229.74 to $229.87 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F2

The price of $228.9485 per share represents a weighted average of sales prices ranging from $228.53 to $229.525 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Remarks

On May 17, 2024, Labcorp Holdings Inc. ("LHI") became the successor of Laboratory Corporation of America Holdings ("LCAH") pursuant to LCAH's reorganization into a new holding company structure (the "Reorganization"). The Reorganization resulted in LHI becoming a parent holding company of LCAH but did not alter the proportionate interests of LCAH security holders.

Read the full filing on SEC EDGAR (opens in a new tab)